Antiviral InteliStrat Inc.

In May 2011, the FDA has approved two new drugs to treat chronic hepatitis C (HCV) infection. The two drugs, Boceprevir (Victrelis) from Merck & Co. and Telaprevir (Incivek) from Vertex (in collaboration with Tibotec), both act as inhibitors of HCV's protease enzyme. This is the first time in...

On April 27 and 28, the FDA's Antiviral Drugs Advisory Committee reviewed all available data presented to support approval of two new molecules developed separately by Merck & Co. (initially by Schering-Plough) and Vertex Pharmaceuticals for the treatment of chronic HCV infection. The two...

In a paper published in Journal of Biological Chemistry (Dec. 10 issue), Kennedy et al. from University of Rochester Medical Center and Emory University reported evidence that HIV has developed an original strategy to replicate efficiently in non-dividing macrophages despite the absence of...

Washington State Convention Center, Seattle (WA), USA -  March 5-8, 2012     http://www.retroconference.org/2012/

Istanbul, Turkey - March 23-26, 2012   http://www.themacraegroup.com/2012-symposia

Hôtel Delta, Montréal, Québec, Canada; 15-16 Mars 2012   http://www.symposiumsida.ca